Safety Data: Cyclobenzaprine AEs with Incidences > 3%
In the double-blind studies the most commonly reported AEs:
- Somnolence, dry mouth, headache, asthenia/fatigue, nausea, and dizziness
-
- Incidences of somnolence, dry mouth, asthenia/fatigue, and dizziness were found to be dose-related compared to placebo